Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed for type 2 diabetes and weight management in the UK Dizziness may result from dehydration due to gastrointestinal side effects, hypoglycaemia when combined with other diabetes medications, or reduced caloric intake Seek urgent medical attention if dizziness occurs with chest pain, severe headache, stroke symptoms, loss of consciousness, or severe abdominal pain Management includes maintaining adequate hydration, rising slowly from sitting or lying positions, monitoring blood glucose levels, and ensuring balanced nutrition Report persistent or concerning symptoms to your GP or via the MHRA Yellow Card Scheme for ongoing medication safety monitoring Table of Contents Understanding Mounjaro and Its Common Side Effects Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes mellitus

Avoid taking glutathione with meals food increases stomach pH variability and prolongs exposure to the acidic environment that degrades the gamma-peptide bond
Last year, she performed 250 bariatric surgeries, a number she said has held steady despite the rise of GLP-1 drugs
Hes unsure of what hes going to do when he runs out later this month, and he is spending time scouring Reddit and Facebook forums to find which telehealth companies are still offering versions of the drugs
Other Side Effects of GLP-1 Weight Loss Drugs In addition to gastrointestinal troubles, other side effects are possible